Back

Should measurement of elevated Lipoprotein a influence recommendations for treatment target for LDL-C?

11 April 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Risk Factors and Prevention - Lipids Lipids EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Doctor Joanna Gilis-Januszewski

Heart and Diabetes Center NRW, Bad Oeynhausen (Germany)

15 More presentations in this session

Presentation thumbnail
Verification of the dutch criteria for familial hypercholesterolemia among a contingent of patients in southern Bulgaria
Doctor L. Kitova (Plovdiv, BG)
Presentation thumbnail
Lipid control in very high cardiovascular risk patients: what is the trend?
Doctor S. Cardoso Torres (Porto, PT)
Abstract
Presentation thumbnail
Physician-related factors associated with adherence to national guidelines for dyslipidemia management in primary care
Professor N. Pogosova (Moscow, RU)
Abstract
Presentation thumbnail
Cardiovascular risk according to SCORE and lipoprotein (a) - Does the association exist in Saint Petersburg population?
Doctor E. Kolesova (Saint-Petersburg, RU)
Abstract
Presentation thumbnail
The role of lipoprotein a as a cardiovascular risk factor in primary prevention screening
Doctor J. Gilis-Januszewski (Bad Oeynhausen, DE)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Risk Factors and Prevention - Lipids

The Event

Event poster

EuroPrevent 2019

11 April - 13 April 2019
You may be interested in
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Congress Presentation
Lipid control in cardiovascular patients
thumbnail
Congress Presentation
Lipidomics to fine-tune cardiovascular risk prediction and personalised treatment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources